PRVCF (PreveCeutical Medical) Short-Term Debt: $3.39 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PreveCeutical Medical Short-Term Debt?

PreveCeutical Medical PRVCF -4.69% Short-Term Debt is $3.39 Mil as of Dec. 2025. The stock has 3 warning signs investors should review.

PreveCeutical Medical's Short-Term Debt for the quarter that ended in Dec. 2025 was $3.39 Mil.

PreveCeutical Medical's quarterly Short-Term Debt declined from Jun. 2025 ($3.28 Mil) to Sep. 2025 ($3.28 Mil) but then increased from Sep. 2025 ($3.28 Mil) to Dec. 2025 ($3.39 Mil).

PreveCeutical Medical's annual Short-Term Debt increased from Dec. 2023 ($2.90 Mil) to Dec. 2024 ($3.09 Mil) and increased from Dec. 2024 ($3.09 Mil) to Dec. 2025 ($3.39 Mil).

PreveCeutical Medical Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

PreveCeutical Medical Short-Term Debt Related Terms

PreveCeutical Medical Short-Term Debt Historical Data

* Premium members only.

The historical data trend for PreveCeutical Medical's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PreveCeutical Medical Short-Term Debt Chart

PreveCeutical Medical Annual Data
Trend Jul16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.98 2.42 2.90 3.09 3.39

PreveCeutical Medical Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.09 3.16 3.28 3.28 3.39
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $3.39 Mil mean?
PreveCeutical Medical (PRVCF) has a Short-Term Debt of $3.39 Mil as of Dec. 2025.
Is PreveCeutical Medical's Short-Term Debt too high?
PreveCeutical Medical's current Short-Term Debt is $3.39 Mil.
How does PreveCeutical Medical's Short-Term Debt compare to VRTX and REGN?
PreveCeutical Medical's Short-Term Debt of $3.39 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Biotechnology company?
A good Short-Term Debt depends on the Biotechnology industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. PreveCeutical Medical's current Short-Term Debt is $3.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PreveCeutical Medical stock overvalued right now?
PreveCeutical Medical (PRVCF) has a current Short-Term Debt of $3.39 Mil. The current Short-Term Debt is $3.39 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For PreveCeutical Medical (PRVCF), the current Short-Term Debt is $3.39 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PreveCeutical Medical Business Description

Other Exchanges 18H0:GermanyPREV:Canada
Address 550 Burrard Street, Bentall 5, Suite 2501, Vancouver, BC, CAN, V6C 2B5
PreveCeutical Medical Inc is a health sciences company. The principal business activity of the company is the development of options for preventive and curative therapies utilizing organic and nature-identical products. The company is engaged in licensing, branding, and marketing nutraceutical and wellness products.